Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Amgen
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
Brodalumab in Subjects with Psoriatic Arthritis
To evaluate the efficacy of brodalumab, (210 mg every 2 weeks (Q2W); and 140 mg Q2W) compared to placebo, in subjects with psoriatic arthritis, as measured by the proportion of subjects achieving an A...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
A Phase 1b/2 Trial of AMG 479 or AMG 102 in Combination With Platinum-based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer
Part 1: To identify a dose of AMG 479 in combination with etoposide plus carboplatin and/or etoposide plus cisplatin and of AMG 102 in combination with etoposide plus carboplatin and/or etoposide plu...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
Study to assess the safety and efficacy of evolocumab in children aged 10 to 17 years with Heterozygous Familial Hypercholesterolemia or Homozygous Familial Hypercholesterolemia
To describe the safety and tolerability of 80 weeks of SC evolocumab when added to standard of care in pediatric subjects 10 to 17 years of age with HeFH or HoFH.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
Open-Label Access Protocol of Denosumab for Subjects with Advanced Cancer
To facilitate the access of denosumab for subjects with advanced cancer who have participated in a denosumab phase 3 study until denosumab is approved and available for sale Safety Objective: To f...
Country
None
organs
None
Specialty
None
unknown
More information
Man
Between 30 years
and 99 years
Amgen
Update Il y a 6 ans
Essai de phase 3 randomisé en double aveugle comparant la survenue ou l'aggravation d'opacifications du cristallin, chez des patients ayant un cancer non métastatique de la prostate recevant le dénosumab pour le traitement d’une perte osseuse due à un traitement de privation androgénique.
L’objectif de cet essai est d’évaluer l’effet du dénosumab sur la survenue ou l'aggravation d'opacifications du cristallin, chez des patients ayant un cancer non métastatique de la prostate. Les pati...
Country
France
organs
Prostate
Specialty
Thérapies Ciblées
Essai ouvert aux inclusions
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
The trial is designed to determine the efficacy and safety of ABP 798 compared with rituximab in subjects with CD 20 positive B-cell non Hodgkin lymphoma
To evaluate the efficacy of ABP 798 compared with rituximab
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
AMG 337 for the Treatment of Gastric, Esophageal and Gastroesophageal Junction Cancers, and Other Solid Tumors AMG 337 για τη θεραπεία των γαστρικών, οισοφαγικών και γαστρο-οισοφαγικών καρκίνων, και άλλων συμπαγών όγκων
To determine antitumor activity of AMG 337 in subjects with MET amplified G/GEJ/E adenocarcinoma. Να καθοριστεί η αντικαρκινική δράση του AMG 337 σε ασθενείς με αδενοκαρκίνωμα Σ/ΓΟΣ/Ο που εμφανί...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
A study evaluating how AMG 344 effects the duration that subjects with angina are able to run on a treadmill
To evaluate the effect of AMG 334 compared to placebo on exercise capacity in subjects with stable angina as measured by total exercise time (TET) during an exercise treadmill test (ETT).
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
To determine if the treatment of AMG 479 at 12 mg/kg and/or 20 mg/kg in combination with gemcitabine improves overall survival (OS) as compared with placebo in combination with gemcitabine in subjects...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
A study to find out more about the effect of AMG 181 in people with moderate to severe ulcerative colitis Μια Μελέτη για την εύρεση περισσοτέρων δεδομένων σχετικά με την επίδραση του AMG181 σε ασθενείς με Μέτρια έως Σοβαρή Ελκώδη Κολίτιδα
To evaluate the effect of AMG 181 on induction of remission in subjects with moderate to severe UC at week 8 as assessed by a total Mayo Score ≤ 2 points, with no individual subscore > 1 point
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
11
12
13
14
15
16
17
18
19
20
Next